ビーエムジー List of Products and Services

Our medical-grade biodegradable and absorbable polymers are produced in facilities compliant with ISO 13485 and are supplied worldwide under the brand name "BioDegmer." They can be processed into a wide variety of shapes and are suitable for a broad range of applications in the medical field. Additionally, their excellent biocompatibility, biodegradability, and flexible processing characteristics make them an ideal innovative solution for enhancing patients' quality of life (QOL). We also accommodate small quantity orders for sales. Please feel free to consult us. 【Product Lineup (Excerpt)】 ■ Polyglycolic acid "PGA" ■ Glycolic acid/L-lactic acid copolymer "PGLA" ■ L-lactic acid/ε-caprolactone copolymer "LCL" ■ Poly-L-lactic acid "PLLA" ■ Poly-p-dioxanone "PDO" *For more details, please refer to the PDF materials or feel free to contact us.

Poly-p-dioxanone (PDO) is obtained by using p-dioxanone as a monomer and performing ring-opening polymerization. It is mainly processed into biodegradable sutures and is also used as a raw material for new medical devices. Due to its flexible processing characteristics, it can be shaped into various forms. Our BioDegmer is produced in facilities compliant with ISO 13485, can be processed into a wide variety of shapes, and is used in a broad range of applications in the medical field. 【Features】 - Mainly processed into biodegradable sutures - Flexible processing characteristics - Capable of being shaped into various forms - Properties: crystalline, insoluble (except for low molecular weight variants), flexibility *For more details, please refer to the PDF document or feel free to contact us.

The "L-lactic acid/ε-caprolactone copolymer (LCL)" is obtained by using L-lactide (the cyclic dimer of lactic acid) and ε-caprolactone as monomers and performing ring-opening polymerization of them. LCL (75:25) is primarily processed into biodegradable sutures and marketed, while LCL (50:50) is used as an artificial dura mater. When used as sutures, the filaments are flexible, allowing even thick filaments to be used as single monofilaments. Our BioDegmer is produced in facilities compliant with ISO 13485, can be processed into a variety of shapes, and is used in a wide range of applications in the medical field. 【Features】 ■ Mainly processed into biodegradable sutures ■ Flexible processing characteristics ■ Capable of being processed into various shapes ■ Properties: Amorphous, flexible *For more details, please refer to the PDF document or feel free to contact us.

"Poly-DL-lactic acid (PDLLA)" is obtained by using lactide (the cyclic dimer of lactic acid) as a monomer and performing ring-opening polymerization. Unlike crystalline poly-L-lactic acid (PLLA) and poly-D-lactic acid, it has an amorphous structure with L-lactic acid units and D-lactic acid units arranged randomly. It is mainly used for (biodegradable) sutures and stent coatings, and recently, development for new absorbable devices is also underway. 【Features】 ■ Mainly used for sutures and stent coating applications ■ Flexible processing characteristics ■ Capable of being processed into various shapes ■ Properties: Amorphous, transparent *For more details, please refer to the PDF document or feel free to contact us.

"Poly-D-lactic acid (PDLA)" is obtained by using lactide (the cyclic dimer of lactic acid) as a monomer and performing ring-opening polymerization. It has the same properties and performance as PLLA polymer and can be substituted for PLLA, so it is rarely used alone. When PLLA and stereo complex (scPLA) are formed, phenomena such as an increase in melting point and improvement in mechanical properties occur, leading to ongoing research and development of scPLA. Our BioDegmer is produced in facilities compliant with ISO 13485, can be processed into a wide variety of shapes, and is used in a broad range of applications in the medical field. [Features] ■ Has the same properties and performance as PLLA polymer ■ Flexible processing characteristics ■ Capable of being processed into various shapes ■ Properties: Crystallinity, transparency, heat resistance (when stereo complexed) *For more details, please refer to the PDF document or feel free to contact us.

Poly-L-lactic acid (PLLA) is obtained by using lactide (the cyclic dimer of lactic acid) as a monomer and performing ring-opening polymerization. L-lactic acid and D-lactic acid have the same chemical properties, differing only in their stereostructure. Therefore, the PLLA polymer and PDLA polymer differ only in their stereostructure, with their properties being almost unchanged. However, the PDLLA polymer exhibits different properties due to its molecular chain stereostructure, which is distinct from both PLLA and PDLA polymers. Our BioDegmer is produced in facilities that comply with ISO 13485, can be processed into a wide variety of shapes, and is used in a broad range of applications in the medical field. [Features] - Mainly processed into biodegradable bone fixation materials - Also used as anti-adhesion membranes and stents - Flexible processing characteristics - Capable of being processed into various shapes - Properties: crystalline, transparent, heat-resistant (when stereocomplexed) *For more details, please refer to the PDF document or feel free to contact us.

The "Glycolic Acid/Lactic Acid Copolymer (PGDLLA)" is obtained by using glycolide (the cyclic dimer of glycolic acid) and lactide (the cyclic dimer of lactic acid) as monomers and polymerizing them through ring-opening polymerization. Lactide can be classified into three types (L-lactide, D-lactide, and DL-lactide) due to its optical activity, so we refer to the copolymer of glycolide and DL-lactide as "PGDLLA." Our BioDegmer is produced in facilities compliant with ISO 13485, can be processed into a wide variety of shapes, and is used in a broad range of applications in the medical field. 【Features】 ■ Obtained through ring-opening polymerization ■ Flexible processing characteristics ■ Capable of being processed into various shapes ■ Properties: Insoluble (high glycolide content) *For more details, please refer to the PDF document or feel free to contact us.

The "Glycolic Acid/L-Lactic Acid Copolymer (PGLA)" is obtained by using glycolide (the cyclic dimer of glycolic acid) and lactide (the cyclic dimer of lactic acid) as monomers and performing ring-opening polymerization of these compounds. Lactide can be classified into three types (L-lactide, D-lactide, and DL-lactide) due to its optical activity, so we refer to the copolymer of glycolide and L-lactide as "PGLA." Our BioDegmer is produced in facilities compliant with ISO 13485, can be processed into a wide variety of shapes, and is used in a broad range of applications in the medical field. 【Features】 ■ Obtained through ring-opening polymerization ■ Flexible processing characteristics ■ Capable of being processed into various shapes ■ Properties: Insoluble (high glycolide content) *For more details, please refer to the PDF document or feel free to contact us.

Polyglutamic acid (PGA) is obtained by using glycolide (the cyclic dimer of glycolic acid) as a monomer and performing ring-opening polymerization. Our BioDegmer is produced in facilities compliant with ISO 13485, can be processed into a variety of shapes, and is used in a wide range of applications in the medical field. Its excellent biocompatibility, biodegradability, and flexible processing characteristics make it an ideal innovative solution to contribute to the improvement of patients' quality of life (QOL). [Features] - Can be used as an artificial dura mater reinforcement material, etc. - Flexible processing characteristics - Capable of being processed into various shapes - Properties: crystalline, poorly soluble (excluding low molecular weight variants) *For more details, please refer to the PDF document or feel free to contact us.

"Biodegmar" is a medical-grade biodegradable and absorbable polymer that can be processed into a variety of shapes and is used in a wide range of applications in the medical field. Our company leverages over 20 years of experience under a strict manufacturing and quality control system based on the international quality management system ISO13485, which is required for medical devices, to provide a diverse range of high-quality custom-made polymers tailored to our customers' needs. We aim to be the ideal innovative solution provider to contribute to improving our customers' productivity and enhancing patients' quality of life (QOL). [Features] ■ Excellent biocompatibility and biodegradability ■ Flexible processing characteristics ■ Can be processed into various shapes, offering extensive application possibilities ■ Polymers can be polymerized according to requests regarding molecular weight and copolymer composition ratios *For more details, please refer to the PDF document or feel free to contact us.

"BioDegmer Filament" is a 3D printer filament with excellent biocompatibility and biodegradability. It can be used in a wide range of applications in the medical field, such as scaffolds for implants and cell/tissue regeneration. By creating 3D models, it allows for hands-on examination of actual models, which is expected to shorten the time required for strength and precision verification, as well as testing and validation. [Features] - For research and development in the medical field - Filament diameter: 1.75mm - Consultation available for prototyping and evaluation of printed products, structural design, and 3D data creation *For more details, please refer to the materials. Feel free to contact us with any inquiries.